Circulating miR-10b soluble urokinase-type plasminogen activator receptor and plasminogen activator inhibitor-1 as predictors of non-small cell lung cancer progression and treatment response.
A case of mosaic deletion of paternally-inherited PLAGL1 and two cases of upd(6)mat add to evidence for PLAGL1 under-expression as a cause of growth restriction.
Circulating Soluble Urokinase Plasminogen Activator Receptor as a Predictive Indicator for COVID-19-Associated Acute Kidney Injury and Mortality: Clinical and Bioinformatics Analysis.
Higher Cerebrospinal Fluid Soluble Urokinase-type Plasminogen Activator Receptor But Not Interferon gamma-inducible Protein 10 Correlate With Higher Working Memory Deficits.
." trans "Poder pronostico de mortalidad a corto plazo del receptor soluble activador del plasminogeno tipo uroquinasa (suPAR) en los pacientes atendidos en urgencias por infeccion.
Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19.
We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.